Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being — Stella

Home/Chronic Pulmonary Aspergillosis/

View on ClinicalTrials.gov

Recruiting

Back to Chronic Pulmonary Aspergillosis trials

Trial locations(3 sites)

United Kingdom

Ninewells Hospital & Medical School, Dundee

Imperial College London, London

Manchester NHS Foundation Trust, Manchester

Key details

Sponsor

Imperial College London

Collaborators

Manchester University NHS Foundation Trust, Tayside Medical Science Centre

Enrollment target

~100 participants

Started

November 2024

Primary completion

August 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.